PMID- 10471319 OWN - NLM STAT- MEDLINE DCOM- 19991005 LR - 20191210 IS - 0014-4827 (Print) IS - 0014-4827 (Linking) VI - 251 IP - 2 DP - 1999 Sep 15 TI - PI3-kinase is involved in mitogenic signaling by the oncogenic receptor tyrosine kinase Xiphophorus melanoma receptor kinase in fish melanoma. PG - 340-9 AB - Overexpression of the mutationally activated receptor tyrosine kinase Xiphophorus melanoma receptor kinase (Xmrk) initiates formation of hereditary malignant melanoma in the fish Xiphophorus. In melanoma as well as in a melanoma-derived cell line (PSM) this receptor is highly activated resulting in constitutive Xmrk-mediated mitogenic signaling. In order to analyze mitogenic signaling triggered by Xmrk a possible involvement of phosphatidylinositol 3 (PI3)-kinase in Xmrk signal transduction was examined. Constitutive binding of the p85 adapter subunit of PI3-kinase to the Xmrk receptor was detected in PSM melanoma cells. Further analyses in BHK cells expressing a Xmrk chimera (HER-mrk) showed that p85 association with the intracellular part of Xmrk was dependent on autophosphorylation of the receptor. In vitro binding studies revealed that the interaction is mediated mainly through the N-terminal SH2 domain of p85 which directly binds to a sequence motif around phosphorylated Tyr-983 in the Xmrk carboxy-terminus. In accordance with recruitment of p85 by Xmrk in PSM cells, the PI3-kinase downstream target Akt was found to be highly phosphorylated on Ser-473, indicating efficient PI3-kinase signaling in melanoma cells. PI3-kinase activation was also detected in Xiphophorus melanoma. Moreover, malignant melanomas exhibited an increased level of PI3-kinase activity which was about three times higher than that in benign pigmented lesions. Inhibition of PI3-kinase activity in PSM melanoma cells by both Wortmannin and LY294002 blocked entry into S-phase. Together these data demonstrate that PI3-kinase is a substrate of the oncogenic Xmrk receptor and plays a significant role in mitogenic signaling of melanoma cells and the formation of malignant melanoma in Xiphophorus. CI - Copyright 1999 Academic Press. FAU - Wellbrock, C AU - Wellbrock C AD - Biocenter (Theodor-Boveri Institut), University of Wurzburg, Wurzburg, Germany. wellbrock@biozentrum.uni-wuerzburg.de FAU - Fischer, P AU - Fischer P FAU - Schartl, M AU - Schartl M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Exp Cell Res JT - Experimental cell research JID - 0373226 RN - 0 (Androstadienes) RN - 0 (Chromones) RN - 0 (Fish Proteins) RN - 0 (Morpholines) RN - 0 (Phosphoinositide-3 Kinase Inhibitors) RN - 0 (Proto-Oncogene Proteins) RN - 31M2U1DVID (2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) RN - EC 2.7.10.1 (Xmrk protein, Xiphophorus) RN - XVA4O219QW (Wortmannin) SB - IM MH - Amino Acid Sequence MH - Androstadienes/pharmacology MH - Animals MH - Binding Sites MH - Chromones/pharmacology MH - Enzyme Activation MH - *Fish Proteins MH - Fishes MH - Melanoma, Experimental/enzymology/etiology/*metabolism MH - Mitosis MH - Molecular Sequence Data MH - Morpholines/pharmacology MH - Phosphatidylinositol 3-Kinases/*metabolism MH - Phosphoinositide-3 Kinase Inhibitors MH - Protein Binding MH - Proto-Oncogene Proteins/*metabolism MH - Receptor Protein-Tyrosine Kinases/*metabolism MH - Signal Transduction MH - Tumor Cells, Cultured MH - Wortmannin EDAT- 1999/09/02 00:00 MHDA- 1999/09/02 00:01 CRDT- 1999/09/02 00:00 PHST- 1999/09/02 00:00 [pubmed] PHST- 1999/09/02 00:01 [medline] PHST- 1999/09/02 00:00 [entrez] AID - 10.1006/excr.1999.4580 [doi] AID - S0014-4827(99)94580-9 [pii] PST - ppublish SO - Exp Cell Res. 1999 Sep 15;251(2):340-9. doi: 10.1006/excr.1999.4580.